1 VAS, SG, TTO and PTO An Interactive Introduction.

Slides:



Advertisements
Similar presentations
Comparing different treatments How can we decide?.
Advertisements

Elicitation methods Health care demands exceed resource supply Therefore, rationing is inevitable Many ways by which we can ration health care One is economic.
Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
Emma Frew Introduction to health economics, MSc HEHP, October 2012 Outcomes: part II.
Quality of life and subjective well-being Paul Dolan Director, Centre for Well Being in Public Policy University of Sheffield, Sheffield, UK [But soon.
COCOM Kwaliteit van leven in maat en getal Jan van Busschbach.
Scaling Session Measurement implies “assigning numbers to objects or events…” Distinguish two levels: we can assign numbers to the response levels for.
EHC Workshop on Economics and HTA’s for EU Member Organisations
1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
1 The QALYs debate  Prof. dr. Jan J.V. Busschbach, Ph.D.  Erasmus MC  Institute for Medical Psychology and Psychotherapy.
Big Q and Little Q revisited Christopher McCabe PhD Capital Health Endowed Research Chair in Emergency Medicine Research.
Summary Measures of Population Health: Measuring the impact of disease, injuries and risk factors.
Utility Assessment HINF Medical Methodologies Session 4.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
Health Economics II –2010 Health Economic Evaluations Part III Lecture 2 Cost-effectiveness analysis QALYs and cost-utility analysis Nils-Olov Stålhammar.
Two ways to skin a cat: a comparison of two variants of standard gamble John Brazier and Paul Dolan Prepared for the CHEBS workshop on Elicitation, 9 October.
A RECIPE FOR INCOHERENCE: AVERAGING TIME-TRADEOFF OR STANDARD-GAMBLE UTILITIES ACROSS HEALTH ATTRIBUTES Gordon B. Hazen, IEMS Department, Northwestern.
Modelling Cardinal Utilities from Ordinal Utility data: An exploratory analysis Peter Gilks, Chris McCabe, John Brazier, Aki Tsuchiya, Josh Solomon.
Estimating utilities from individual preference data Some introductory remarks by Tony O’Hagan.
Utilising rank and DCE data to value health status on the ‘QALY’ scale using conventional and Bayesian methods John Brazier and Theresa Cain with Aki Tsuchiya.
Quality of life Assessment introduction
QUALITY OF LIFE ASSESSMENT IN PEOPLE LIVING WITH HIV/AIDS Antonieta Medina Lara HIV/AIDS and STI Knowledge Programme Liverpool School of Tropical Medicine.
1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.
1 EuroQol EQ-5D Jan J. V. Busschbach, Ph.D Psychotherapeutic Centrum ‘De Viersprong’, Halsteren Department of Medical.
Measuring and valuing health outcome Montarat Thavorncharoensap, Ph.D. 1: Faculty of Pharmacy, Mahidol University 2. HITAP, Thailand.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
1 Health Economics  Comparing different allocations  Should we spent our money on Wheel chairs Screening for cancer  Comparing costs  Comparing outcome.
Measuring the “Q” in QALYs for cost- effectiveness analysis: the EuroQol Group’s approach Valuing health outcomes for healthcare decision making using.
Overview of the EQ-5D Purpose and origins of the descriptive system.
1 The valuation of disease-specific questionnaires for QALY analysis  To rescue data in absence of an utility measure  Growth hormone deficiency in adults.
Is healthcare any good for patients? Measuring health outcomes using EQ-5D Professor Paul Kind Principal Investigator Outcomes Research Group Centre for.
Measuring Health Outcomes
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
Health State Unable to perform some tasks at home and/or at work Able to perform all self care activities (eating, bathing, dressing) albeit with some.
317_L26, Mar J. Schaafsma 1 Review of the Last Lecture Are looking at program evaluation in healthcare Three methods: CBA, CEA, CUA discussed CBA,
1 Patient values or values from the general public.
Estimating Outcomes in Decision Analysis Brian Harris MPP Candidate Goldman School of Public Policy University of California, Berkeley.
Outcomes in Decision Analysis: Utilities, QALYs & DALYs, and Discounting DCEA 24 January 2013 James G. Kahn.
1 The valuation of disease-specific health states to facilitate economic evaluation E. Kok, E. Stolk, Jan J. v. Busschbach Address: –Jan v. Busschbach.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 Interactive introduction in Quality of life Assessment Jan J. v. Busschbach, Ph.D. Department of Medical Psychology and Psychotherapy, Erasmus MC
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy Viersprong.
Introductory Statistics Options, Spring 2008 Stat 100: MWF, 11:00 Science Center C. Stat 100: MWF, 11:00 Science Center C. –General intro to statistical.
Sample Size Determination in Studies Where Health State Utility Assessments Are Compared Across Groups & Time Barbara H Hanusa 1,2 Christopher R H Hanusa.
1 Scale recalibration effects in dementia patients and their proxies Sander Arons Dept. of Epidemiology, Biostatistics and HTA Radboud University Nijmegen.
1 Health outcome valuation study in Thailand Sirinart Tongsiri Research degree student Health Services Research Unit, Public Health & Policy Department.
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
Applying Expectancy-value Model to understand Health Preference An Exploratory Study Xu-Hao Zhang Department of Pharmacy National University of Singapore.
Introduction to decision analysis Jouni Tuomisto THL.
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
HERU is supported by the Chief Scientist Office of the Scottish Executive Health Department and the University of Aberdeen. The author accepts full responsibility.
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO Floor van Nooten, Xander Koolman, Werner Brouwer 1 A paper introduced.
Scaling Session Measurement implies assigning numbers to objects or events. In our case, the numbers “weight” responses to questions, so that saying “Yes”
Values Lower Than Death Jan J. v. Busschbach, Ph.D. –Erasmus University Rotterdam institute for Medical Technology Assessment (iMTA) PO box DR.
Copyright © 2014 Pearson Education. All rights reserved Picturing Distributions of Data LEARNING GOAL Be able to create and interpret basic.
Effect of framing of death on health state values obtained from DCEs Dr. Esther W. de Bekker-Grob by Jonker, de.
1 Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
1 Are values cultural determined…..  Many believe that QoL is cultural determined  One of the starting points of the EuroQol group.
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
1 Utilization of Quality of Life Research in Decision-Making and Policy  Prof. Dr. Jan J.V. Busschbach  Erasmus MC, Rotterdam, The Netherlands  Section.
Preference Assessment 1 Measuring Utilities Directly
Prof. Dr. Jan J.V. Busschbach
Effect of framing of death on health state values obtained from DCEs
The valuation of disease-specific questionnaires for QALY analysis
Is healthcare any good for patients
Two types of scoring systems used to measure pain.
Elicitation methods Health care demands exceed resource supply
Presentation transcript:

1 VAS, SG, TTO and PTO An Interactive Introduction

2 Value a health state  Wheelchair  Some problems in walking about  Some problems washing or dressing  Some problems with performing usual activities  Some pain or discomfort  No psychosocial problems

3 Uni-dimensional value  Like the IQ-test measures intelligence  Ratio or interval scale  Difference 0.00 and 0.80 must be 8 time higher than 0.10  Three popular methods have these pretensions  Visual analog scale  Time trade-off  Standard gamble

4 Time Trade-Off  TTO  Wheelchair  With a life expectancy: 50 years  How many years would you trade-off for a cure?  Max. trade-off is 10 years  QALY(wheel) = QALY(healthy)  Y * V(wheel) = Y * V(healthy)  50 V(wheel) = 40 * 1  V(wheel) =.8

5 Standard Gamble  SG  Wheelchair  Life expectancy is not important here  How much are risk on death are you prepared to take for a cure?  Max. risk is 20%  wheels = (100%-20%) life on feet  V(Wheels) = 80% or.8

6 Visual Analogue Scale  VAS  Also called “category scaling”  From psychological research  “How is your quality of life?”  “X” marks the spot  Rescale to [0..1]  Different anchor point possible:  Normal health (1.0) versus dead (0.0)  Best imaginable health versus worse imaginable health Dead Normal health X

7 Consistent picture of difference 103 students

8 Health economics prefer TTO/SG  Visual analogue scale  Easy  No trade-off: no relation to QALY No interval proportions  Standard Gamble / Time trade-Off  Less easy  Trade-off: clear relation to QALY Interval proportions  Little difference between SG and TTO